← Evidence map

ReviewFrontiers in oncology2021

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges.

Zhitao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34869005